查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417982

生物分子軟體市場報告：2030 年趨勢、預測與競爭分析

Biomolecule Software Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物分子軟體趨勢與預測

預計 2024 年至 2030 年，全球生物分子軟體市場將以 15.0% 的複合年成長率成長。該市場的主要驅動力是藥物研發和市場開拓中對生物分子軟體的需求不斷成長以及個人化醫療的日益採用。全球生物分子軟體市場的未來充滿希望，醫院、診所和研究中心市場充滿機會。

生物分子軟體市場洞察

Lucintel 預測，由於 Windows 的易用性以及與現有基礎設施的兼容性，Windows 在預測期內將出現最高的成長。

由於分析患者資料、確定藥物研發標靶和製定個人化治療計劃的需求不斷增加，預計醫院將在市場上實現最高成長。

由於其強大的製藥和生物技術產業，北美在預測期內仍將是最大的地區。

常問問題

Q1. 生物分子軟體市場的成長預測如何？

A1. 2024年至2030年，全球生物分子軟體市場預計將以15.0%的複合年成長率成長。

Q2.影響生物分子軟體市場成長的關鍵促進因素是什麼？

A2. 該市場的主要驅動力是藥物研發和市場開拓中對生物分子軟體的需求不斷成長以及個人化醫療的日益採用。

Q3.生物分子軟體市場的主要部分是什麼？

A3. 生物分子軟體市場的未來性廣闊，醫院、診所和研究中心市場都有機會。

Q4. 生物分子軟體市場的主要企業有哪些？

A4.主要的生物分子軟體公司如下。

  • Hamilton Thorne
  • Hermes Medical Solution
  • INDICAL BIOSCIENCE
  • Lexogen

Q5. 未來哪個細分領域將成為生物分子軟體市場最大的領域？

A5.Lucintel 預測，由於易於使用以及與現有基礎設施的兼容性，Windows 將在預測期內實現最高成長。

Q6. 未來五年生物分子軟體市場預計在哪個地區成長最快？

A6. 由於製藥和生技產業的實力，北美在預測期內將繼續成為最大的地區。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球生物分子軟體市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物分子軟體市場趨勢（2018-2023）與預測（2024-2030）
  • 按功能類型分類的全球生物分子軟體市場
    • Windows
    • Linux
    • MacOS
  • 全球生物分子軟體市場（按應用）
    • 醫院
    • 診所
    • 研究中心

第4章 2018-2030年市場趨勢及預測分析：分地區

  • 全球生物分子軟體市場（按地區）
  • 北美生物分子軟體市場
  • 歐洲生物分子軟體市場
  • 亞太地區生物分子軟體市場
  • 其他地區生物分子軟體市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按功能類型分類的全球生物分子軟體市場成長機會
    • 全球生物分子軟體市場成長機會（按應用）
    • 全球生物分子軟體市場按地區成長機會
  • 全球生物分子軟體市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球生物分子軟體市場的產能擴張
    • 全球生物分子軟體市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Hamilton Thorne
  • Hermes Medical Solution
  • INDICAL BIOSCIENCE
  • Lexogen
簡介目錄

Biomolecule Software Trends and Forecast

The future of the global biomolecule software market looks promising with opportunities in the hospital, clinic, and research center markets. The global biomolecule software market is expected to grow with a CAGR of 15.0% from 2024 to 2030. The major drivers for this market are increasing demand for biomolecule software in drug discovery and development and growing adoption of personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Biomolecule Software by Segment

The study includes a forecast for the global biomolecule software by function type, application, and region.

Biomolecule Software Market by Function Type [Shipment Analysis by Value from 2018 to 2030]:

  • Windows
  • Linux
  • Macos

Biomolecule Software Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital
  • Clinic
  • Research Center

Biomolecule Software Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biomolecule Software Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomolecule software companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomolecule software companies profiled in this report include-

  • Hamilton Thorne
  • Hermes Medical Solution
  • Indical Bioscience
  • Lexogen

Biomolecule Software Market Insights

Lucintel forecasts that window is expected to witness the highest growth over the forecast period due to ease of use and compatible with existing infrastructure.

Within this market, hospital is expected to witness the highest growth due to growing demand for analyzing patient data, identifying drug targets, and developing personalized treatment plans.

North America will remain the largest region over the forecast period due to strong pharmaceutical and biotechnology industry.

Features of the Global Biomolecule Software Market

Market Size Estimates: Biomolecule software market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomolecule software market size by various segments, such as by function type, application, and region in terms of value ($B).

Regional Analysis: Biomolecule software market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different function types, applications, and regions for the biomolecule software market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomolecule software market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for biomolecule software market?

Answer: The global biomolecule software market is expected to grow with a CAGR of 15.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the biomolecule software market?

Answer: The major drivers for this market are increasing demand for biomolecule software in drug discovery and development and growing adoption of personalized medicine.

Q3. What are the major segments for biomolecule software market?

Answer: The future of the biomolecule software market looks promising with opportunities in the hospital, clinic, and research center markets.

Q4. Who are the key biomolecule software market companies?

Answer: Some of the key biomolecule software companies are as follows.

  • Hamilton Thorne
  • Hermes Medical Solution
  • Indical Bioscience
  • Lexogen

Q5. Which biomolecule software market segment will be the largest in future?

Answer: Lucintel forecasts that window is expected to witness the highest growth over the forecast period due to ease of use and compatible with existing infrastructure.

Q6. In biomolecule software market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to strong pharmaceutical and biotechnology industry.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biomolecule software market by function type (windows, linux, and macos), application (hospital, clinic, and research center), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomolecule Software Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biomolecule Software Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biomolecule Software Market by Function Type
    • 3.3.1: Windows
    • 3.3.2: Linux
    • 3.3.3: MacOS
  • 3.4: Global Biomolecule Software Market by Application
    • 3.4.1: Hospital
    • 3.4.2: Clinic
    • 3.4.3: Research Center

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biomolecule Software Market by Region
  • 4.2: North American Biomolecule Software Market
    • 4.2.2: North American Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.3: European Biomolecule Software Market
    • 4.3.1: European Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.3.2: European Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.4: APAC Biomolecule Software Market
    • 4.4.1: APAC Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.4.2: APAC Biomolecule Software Market by Application: Hospital, Clinic, and Research Center
  • 4.5: ROW Biomolecule Software Market
    • 4.5.1: ROW Biomolecule Software Market by Function Type: Windows, Linux, and MacOS
    • 4.5.2: ROW Biomolecule Software Market by Application: Hospital, Clinic, and Research Center

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biomolecule Software Market by Function Type
    • 6.1.2: Growth Opportunities for the Global Biomolecule Software Market by Application
    • 6.1.3: Growth Opportunities for the Global Biomolecule Software Market by Region
  • 6.2: Emerging Trends in the Global Biomolecule Software Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biomolecule Software Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomolecule Software Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hamilton Thorne
  • 7.2: Hermes Medical Solution
  • 7.3: INDICAL BIOSCIENCE
  • 7.4: Lexogen